Welcome to the international HTA database

Showing [24038 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2014	NIHR Health Technology Assessment programme	START (STrAtegies for RelaTives) study: a pragmatic randomised controlled trial to determine the clinical effectiveness and cost-effectiveness of a manual-based coping strategy programme in promoting the mental health of carers of people with dementia
2014	HAYES, Inc.	Portable versus non-portable intermittent pneumatic compression for prevention of postoperative deep vein thrombosis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Re-treatment with direct acting antivirals for chronic hepatitis C genotype 1: emerging evidence of clinical effectiveness and safety
2014	HAYES, Inc.	High-resolution anoscopy for the evaluation of anal lesions
2014	Medical Services Advisory Committee (MSAC)	Diagnostic fluorescence in situ hybridisation (FISH) testing for Anaplastic Lymphoma Kinase (ALK) in advanced non-small cell lung cancer (NSCLC) to determine eligibility for crizotinib treatment (co-dependent). (Resubmission)
2014	Canary Health Service	[Urine markers for the prediction of kidney transplant rejection]
2014	HAYES, Inc.	Pronto-7 with rainbow 4D technology (Masimo Corp.) for noninvasive hemoglobin measurement
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Short-acting intramuscular olanzapine for acute agitation: clinical and cost - effectiveness and guidelines
2014	HAYES, Inc.	Minimally invasive thoracotomy for mitral valve replacement
2014	Canary Health Service	[Systematic review of aCGH for the genetic study of pediatric neurodevelopmental disorders]
2014	HAYES, Inc.	Split-night polysomnography for Continuous Positive Airway Pressure (CPAP) titration in adults with obstructive sleep apnea
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Reprocessing of single use medical devices: effectiveness, safety, and guidelines
2014	Andalusian Health Technology Assessment Area (AETSA)	[Alglucosidase alfa (Myozyme ®) in late-onset Pompe disease]
2014	HAYES, Inc.	Noninvasive peripheral arterial tonometry
2014	Canary Health Service	[Surgical treatment of benign melanocytic lesions for the prevention of melanoma]
2014	HAYES, Inc.	X stop interspinous process decompression system (Medtronic Spine LLC) for lumbar spinal stenosis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Aspirating versus not aspirating prior to injection of medication: comparative clinical evidence and guidelines
2014	HAYES, Inc.	Palivizumab (Synagis) prophylaxis for respiratory syncytial virus infection in preterm infants
2014	Canary Health Service	[Monetary value of a quality-adjusted life year: a critical review and appraisal of the literature]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Providing rehabilitation services for seven days versus five days per week: clinical effectiveness and guidelines
2014	HAYES, Inc.	Percutaneous tibial nerve stimulation for the treatment of lower urinary tract dysfunction
2014	NIHR Health Technology Assessment programme	Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	BMI reduction and chronic disease management: clinical evidence
2014	HAYES, Inc.	Preoperative physical therapy for severe osteoarthritis of the knee
2014	NIHR Health Technology Assessment programme	Allopurinol for chronic kidney disease: a systematic review
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suspended ceiling lifts: safety
2014	HAYES, Inc.	Radioactive yttrium-90 microspheres for treatment of primary unresectable liver cancer
2014	NIHR Health Technology Assessment programme	Probiotics for antibiotic-associated diarrhoea (PAAD): a prospective observational study of antibiotic-associated diarrhoea (including Clostridium difficile-associated diarrhoea) in care homes
2014	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C in children and young people: a systematic review and economic evaluation
2014	NIHR Health Technology Assessment programme	Dabrafenib for treating unresectable, advanced or metastatic BRAFV600 mutation-positive melanoma (ID605)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Suctioning for respiratory blockage: clinical effectiveness and guidelines
2014	HAYES, Inc.	Radioactive yttrium-90 microspheres for treatment of primary unresectable liver cancer as a bridge to transplantation or surgery
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cleaning wipes for prevention of C. difficile infection in the hospital setting: clinical effectiveness
2014	NIHR Health Technology Assessment programme	Assessing the risk of self-harm in an adult offender population: an incidence cohort study
2014	HAYES, Inc.	Ultrasound transient elastography for detecting hepatic fibrosis in patients with hepatitis C
2014	NIHR Health Technology Assessment programme	What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fecal bacteriotherapy for adult patients with recurrent clostridium difficile infection: update of clinical, cost-effectiveness, and guidelines
2014	Andalusian Health Technology Assessment Area (AETSA)	[Prognostic genomic tests in early breast cancer: MammaPrint® and Oncotype DX®]
2014	Agency for Healthcare Research and Quality (AHRQ)	Decision aids for cancer screening and treatment
2014	HAYES, Inc.	Virtual bronchoscopic navigation for evaluation of peripheral pulmonary lesions
2014	NIHR Health Technology Assessment programme	Interventions for adult eustachian tube dysfunction: a systematic review
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tenofovir disoproxil fumarate (Viread®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Antibacterial sutures for wound closure after surgery: update on clinical effectiveness and guidelines for use
2014	Andalusian Health Technology Assessment Area (AETSA)	[Efficacy, safety and efficiency of platelet rich plasma in the treatment of aseptic nonunion]
2014	Agency for Healthcare Research and Quality (AHRQ)	Therapies for clinically localized prostate cancer: update of a 2008 systematic review
2014	HAYES, Inc.	Agento I.C. silver-coated endotracheal tube (C.R. Bard Inc.) for the prevention of ventilator-associated pneumonia (VAP)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Indacaterol/glycopyrronium (Ultibro® Breezhaler®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Population-based colorectal cancer screening: guidelines
2014	Agency for Healthcare Research and Quality (AHRQ)	Radiotherapy treatments for head and neck cancer update
2014	HAYES, Inc.	Autologous bone marrow-derived mesenchymal stem cell therapy for treatment of nonunion of the lower extremity
2014	NIHR Public Health Research (PHR) programme	Putting Life in Years (PLINY): a randomised controlled trial and mixed-methods process evaluation of a telephone friendship intervention to improve mental well-being in independently living older people
2014	NIHR Health Technology Assessment programme	Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Darunavir (Prezista®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Extracorporeal photopheresis following bone marrow transplant: clinical effectiveness
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Portrait of the use of bisphosphonates and denosumab in patients aged 50 years or older with osteoporosis who are covered by the public prescription drug insurance program]
2014	HAYES, Inc.	BD veritor system for rapid detection of flu A+B (Becton, Dickinson and Company) for detection of Influenza types A and B viral antigens
2014	NIHR Public Health Research (PHR) programme	A pilot feasibility cluster randomised controlled trial of screening and brief alcohol intervention to prevent hazardous drinking in young people aged 14 15 years in a high school setting (SIPS JR-HIGH)
2014	Basque Office for Health Technology Assessment (OSTEBA)	[Geographical mental health map: geographical variation in psychosis and association with environmental factors]
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Tocilizumab (RoActemra®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Post-surgical surveillance for surgical site infections: guidelines
2014	NIHR Health Services and Delivery Research programme	Improving the effectiveness of multidisciplinary team meetings for patients with chronic diseases: a prospective observational study
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Use of long-term left ventricular assist devices for advanced heart failure in Quebec from 2010 to 2012]
2014	HAYES, Inc.	CellSearch circulating tumor cell (CTC) kit (Janssen Diagnostics LLC) for monitoring metastatic breast cancer
2014	NIHR Public Health Research (PHR) programme	A pragmatic evaluation of a family-based intervention for childhood overweight and obesity
2014	Basque Office for Health Technology Assessment (OSTEBA)	[Relationship between use of cannabis and other drugs and psychiatric pathology in adolescents. A proposal of inpatient and outpatient mental health care in the Basque Health Service]
2014	NIHR Health Technology Assessment programme	Clinical and cost-effectiveness of cholecystectomy versus observation/conservative management for preventing recurrent symptoms and complications in adults presenting with uncomplicated symptomatic gallstones or cholecystitis: a systematic review and economic evaluation
2014	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Oral nutrition intake for the prevention of falls in older adults: clinical effectiveness and guidelines
2014	NIHR Health Services and Delivery Research programme	A qualitative study of the knowledge-brokering role of middle-level managers in service innovation: managing the translation gap in patient safety for older persons care
2014	Health Quality Ontario (HQO)	Arthroscopic debridement of the knee: OHTAC recommendation
2014	HAYES, Inc.	ChemoFx assay (Precision Therapeutics Inc.) for prediction of response to chemotherapy for ovarian cancer
2014	NIHR Public Health Research (PHR) programme	Does the Royal Horticultural Society Campaign for School Gardening increase intake of fruit and vegetables in children? Results from two randomised controlled trials
2014	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of brief intervention for excessive alcohol consumption among people attending sexual health clinics: a randomised controlled trial (SHEAR)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Vitamin supplementation for hospitalized adults: clinical evidence and guidelines
2014	NIHR Health Services and Delivery Research programme	A formative evaluation of Collaboration for Leadership in Applied Health Research and Care (CLAHRC): institutional entrepreneurship for service innovation
2014	Health Quality Ontario (HQO)	End-of-life health care in Ontario: OHTAC recommendation
2014	HAYES, Inc.	Collagen meniscus implant (CMI, Menaflex; Ivy Sports Medicine LLC) for treatment of meniscal tears
2014	NIHR Public Health Research (PHR) programme	Outreach programmes for health improvement of Traveller Communities: a synthesis of evidence
2014	Basque Office for Health Technology Assessment (OSTEBA)	[Evaluation of care quality in the national health service towards severe childhood mental disorders. A study in infant/juvenile mental health services]
2014	Medical Advisory Secretariat (MAS)	Multiple intravenous infusions
2014	NIHR Health Technology Assessment programme	Rehabilitation aimed at improving outdoor mobility for people after stroke: a multi-centre randomised controlled study (the Getting out of the House Study)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tools assessing patient-reported outcome measures in cancer patients: accuracy and guidelines
2014	NIHR Health Services and Delivery Research programme	Development of methodological guidance, publication standards and training materials for realist and meta-narrative reviews: the RAMESES (Realist And Meta-narrative Evidence Syntheses - Evolving Standards) project
2014	Health Quality Ontario (HQO)	Arthroscopic debridement of the knee: an evidence update
2014	HAYES, Inc.	Computed tomography-guided percutaneous microwave ablation for lung nodules
2013	HAYES, Inc.	CyberKnife robotic radiosurgery system (Accuray Inc.) for treatment of prostate cancer
2013	HAYES, Inc.	Impella Recover LP 2.5 percutaneous cardiac support system (Abiomed Inc.) for emergent hemodynamic support in patients with cardiogenic shock
2013	HAYES, Inc.	Lokomat (Hocoma AG) Driven Gait Orthosis (DGO) for use in children with cerebral palsy
2013	Andalusian Health Technology Assessment Area (AETSA)	[Breast cancer ablation with radiofrequency. Systematic review]
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Music therapy - update on the evidence about its indications]
2013	The HTA Center of the Stockholm County Council/Gotland	Cyanoacrylate and postoperative infections
2013	Health Quality Ontario (HQO)	Effectiveness and safety of thrombolytics for the treatment of ischemic stroke: a rapid review
2013	Canary Health Service	[Cost-effectiveness of newborn screening for sickle cell anemia]
2013	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of minimally invasive techniques to manage varicose veins: a systematic review and economic evaluation
2013	HAYES, Inc.	Impella recover LP 2.5 percutaneous cardiac support system (Abiomed Inc.) for patients undergoing high-risk percutaneous coronary intervention (PCI)
2013	HAYES, Inc.	Intratympanic steroid injection for ménière's disease
2013	HAYES, Inc.	Magnetic Resonance Guided Focused Ultrasound Therapy (MRgFUS) (ExAblate; InSightec Ltd.) for palliation of painful bone metastases
2013	Andalusian Health Technology Assessment Area (AETSA)	[Effectiveness and safety of MRI 3 tesla versus MRI 1.5 tesla. Systematic Review]
2013	Institute for Clinical Effectiveness and Health Policy (IECS)	[Intra-articular use of hyaluronic acid in the treatment of knee osteoarthritis]
2013	The HTA Center of the Stockholm County Council/Gotland	Risks associated with planned home delivery for nulliparous women